RXRX Latest Press Releases

-- October 26, 2026 --

Recursion to Host Webinar Focused on Updated REC-4881 (FAP) Data from CGA-IGC on Tuesday, November 3 Globe Newswire 4:05 PM

-- October 15, 2026 --

Recursion Announces Sanofi Options Potential First-in-Class Immunology Development Candidate from Their Collaboration Globe Newswire 8:45 AM

Recursion Announces Pricing of $200 Million Underwritten Offering of Class A Common Stock Globe Newswire 8:30 AM

Recursion Announces $200 Million Oversubscribed Follow-On Offering, Clinical Data Updates, and Partnership Milestone Globe Newswire 8:22 AM

-- September 21, 2026 --

Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion's RNA Foundation Model Business Wire 9:14 AM

-- September 3, 2026 --

The Market Just Told You Which Layer Of AI Biology It Is Paying For Globe Newswire 2:10 PM

-- August 5, 2026 --

Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program Globe Newswire 6:30 AM

-- August 4, 2026 --

Recursion to Participate in Upcoming Investor Conferences Globe Newswire 8:00 AM

-- July 31, 2026 --

Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules Globe Newswire 4:30 PM

-- July 29, 2026 --

Recursion to Report Second Quarter 2026 Business Updates and Financial Results on August 5th Globe Newswire 8:30 AM

-- July 1, 2026 --

As AI Models Become Commodities, One Bio-Native AI Company Just Moved to Patent the Thing That Actually Compounds: the Data PRNewswire 9:01 AM

-- June 30, 2026 --

A Clinical-Stage Cancer Company Is Putting AI to Work Designing Its Next Generation of Tumor-Targeting Drugs PRNewswire 9:00 AM

-- June 16, 2026 --

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It PRNewswire 8:45 AM

-- June 2, 2026 --

Recursion to Participate in Upcoming Investor Conferences Globe Newswire 8:00 AM

-- May 29, 2026 --

Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules Globe Newswire 4:30 PM

Market Data Delayed 15 Minutes